Answers are grounded in this paper and cite their sources.
, with signaling dynamics predicting metabolic output. This pharmacological asymmetry provides strong directional evidence for pathway ordering, but it does not constitute definitive molecular proof of causality because inhibitor specificity is incomplete and no genetic or rescue experiment was performed.
No takes yet. Share an insight, caveat, or question.
Perveen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: